Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.

× No keyword cloud information.

17 in total

1. Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.

Authors: Sean J Barbour; Monica C Beaulieu; Nadia Y Zalunardo; Alex B Magil
Journal: Nephrol Dial Transplant Date: 2011-06-01 Impact factor: 5.992

2. Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia.

Authors: N Yahata; Y Kawanishi; S Okabe; Y Kimura; T Okada; M Otani; T Shimizu; T Nakao; K Ohyashiki
Journal: Am J Nephrol Date: 2000 Sep-Oct Impact factor: 3.754

3. Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects.

Authors: Meritxell Garcia Alzamora; Markus Schmidli; Urs Hess; Richard Cathomas; Roger von Moos
Journal: Onkologie Date: 2006-03-22

Review 4. Rare association of chronic lymphocytic leukemia/small lymphocytic lymphoma, ANCAs, and pauci-immune crescentic glomerulonephritis.

Authors: Kammi J Henriksen; Richard B Hong; Maria I Sobrero; Anthony Chang
Journal: Am J Kidney Dis Date: 2010-10-25 Impact factor: 8.860

5. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.

Authors: W G Wierda; M J Cantwell; S J Woods; L Z Rassenti; C E Prussak; T J Kipps
Journal: Blood Date: 2000-11-01 Impact factor: 22.113

6. A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.

Authors: W G Wierda; J E Castro; R Aguillon; D Sampath; A Jalayer; J McMannis; C E Prussak; M Keating; T J Kipps
Journal: Leukemia Date: 2010-09-30 Impact factor: 11.528

7. Glomerulopathies with fibrillary deposits.

Authors: J A King; R M Culpepper; G R Corey; J A Tucker; G Lajoie; D N Howell
Journal: Ultrastruct Pathol Date: 2000 Jan-Feb Impact factor: 1.094

Review 8. Tumour lysis syndrome: new therapeutic strategies and classification.

Authors: Mitchell S Cairo; Michael Bishop
Journal: Br J Haematol Date: 2004-10 Impact factor: 6.998

9. A review of nephrotic syndrome associated with chronic lymphocytic leukemia.

Authors: F D Seney; W R Federgreen; H Stein; M Kashgarian
Journal: Arch Intern Med Date: 1986-01

10. Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.

Authors: J E Castro; J D Sandoval-Sus; J Bole; L Rassenti; T J Kipps
Journal: Leukemia Date: 2008-08-28 Impact factor: 11.528

3 in total

1. Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma.

Authors: Haruka Takahashi; Takashi Sano; Sayumi Kawamura; Keiko Sano; Ryoma Miyasaka; Takuya Yamazaki; Mayuko Sakakibara; Tetsuya Abe; Keiko Hashimoto; Miki Nagaoka; Mariko Kamata; Shokichi Naito; Togo Aoyama; Rika Moriya; Yasuo Takeuchi
Journal: CEN Case Rep Date: 2021-09-26

Review 2. Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Authors: Shveta S Motwani; Leal Herlitz; Divya Monga; Kenar D Jhaveri; Albert Q Lam
Journal: Clin J Am Soc Nephrol Date: 2016-08-15 Impact factor: 8.237

3. A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development.

Authors: Aditi Khandelwal; Martina A Trinkaus; Hassan Ghaffar; Serge Jothy; Marc B Goldstein
Journal: BMC Nephrol Date: 2016-09-29 Impact factor: 2.388

3 in total